Metric Finance
LearnFAQ
LearnFAQ

Learn / MEDP

NASDAQ: MEDP

Medpace Holdings (MEDP) stock, explained like you're 5

Medpace Holdings trades on the Nasdaq under the ticker MEDP. It is a large cap company in the commercial physical & biological resarch industry, part of the healthcare sector, with a market value of about 17.1 billion dollars.

Ticker
MEDP
Exchange
Nasdaq
Sector
Healthcare
Industry
Commercial Physical & Biological Resarch
Size
Large cap, about 17.1 billion dollars

Is Medpace Holdings a small, medium or large cap company?

Yes. Medpace Holdings is a large cap stock. Its market cap, which is the total value of all its shares, is about 17.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Medpace Holdings makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves MEDP stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • CON vs. MEDP: Which Stock Should Value Investors Buy Now? (Yahoo Finance)
  • At $166.73 a share, Medpace (MEDP) EVP Susan E. Burwig exercised options for 3,000 shares. (Stock Titan)
  • Medpace Holdings (MEDP) Following Its Run Higher Looks Pricey Next To Fair Value (Simply Wall Street)
  • Medpace Holdings: Strong Bookings, But Pass Through Flatters Growth And The Valuation Leaves Little Room (Seeking Alpha)
  • Don’t Chase Medpace Stock Here Despite Its Strong Technical Momentum (Yahoo Finance)

Follow MEDP in your daily brief

Each trading day at 5 PM ET we post what happened to Medpace Holdings and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow MEDP

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Medpace Holdings stock

What does Medpace Holdings do?

Medpace Holdings trades on the Nasdaq under the ticker MEDP. It is a large cap company in the commercial physical & biological resarch industry, part of the healthcare sector, with a market value of about 17.1 billion dollars.

What is the ticker symbol for Medpace Holdings?

Medpace Holdings trades under the ticker MEDP on the Nasdaq.

What is Medpace Holdings's market cap?

Medpace Holdings is a large cap stock with a market cap of about 17.1 billion dollars.

How does Medpace Holdings make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves MEDP stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow MEDP stock every day?

Add MEDP to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow MEDP daily

A free brief on Medpace Holdings and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • IQV · Iqvia Holdings
  • INCY · Incyte
  • CRL · Charles River Laboratories International
  • ICLR · Icon PLC

Similar stocks

  • IQVIqvia Holdings
  • INCYIncyte
  • CRLCharles River Laboratories International
  • ICLRIcon PLC

Compare MEDP: MEDP vs IQV, MEDP vs INCY, MEDP vs CRL

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed